510(k) device
miraDry System MD4000
Miramar Labs, Inc. · Instrument For Treatment Of Hyperhidrosis (OUB, Class II) · First FDA decision Jan 28, 2011, newest Jun 19, 2015Acne, psoriasis and other skin conditions
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
8
Naming "miraDry"
MAUDE reports
0
Brand "miraDry", since 2015
PubMed studies
14
Mentioning "miraDry"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing miraDry System MD4000
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "miraDry", any status and sponsor, newest update first.
Johns Hopkins UniversityAcademic, hospital or other
NCT02295891 · 31 participants · Start Nov 2014 · Primary completion Dec 2019
Device: MiraDry ® · For: Axillary Hyperhidrosis
Sites: Baltimore, Maryland
Region ÖstergötlandAcademic, hospital or other
NCT04546438 · 100 participants · Start Sep 4, 2020 · Primary completion Dec 1, 2023
Device: miraDry® · For: Axillary Hyperhidrosis
Sites: Norrköping, Sweden
miraDry, Inc.Not on our public-company list
NCT05546710 · 0 participants · Start Nov 2022 · Primary completion Jun 2023
Device: miraDry treatment · For: Hyperhidrosis; Axillary Hyperhidrosis
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "miraDry", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OUB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "miraDry"[tiab]. The summary above synthesizes these.
- Comparison of Microwave-Based Therapy and Negative-Pressure Suction-Curettage for Axillary Hyperhidrosis and Bromhidrosis: A Retrospective Analysis.
Ge Y, Liu J, Zhang R · Ann Plast Surg · 2024Comparative Study, Research Support, Non-U.S. Gov't
- Three-Year Results Following Microwave Therapy in Patients with Severe Primary Axillary Hyperhidrosis.
Micu E, Fragkou Dragka M, Shayesteh A · Aesthetic Plast Surg · 2026
- A single session of high-energy microwave axillary hyperhidrosis and osmidrosis therapy: Key pretherapeutic assessment and outcome analysis.
Wang YH, Cheng CY, Chang SL, et al. · Lasers Surg Med · 2023Case Reports, Research Support, Non-U.S. Gov't
- Fatal consequence after MiraDry® treatment: Necrotizing fasciitis complicated with streptococcal toxic shock syndrome.
Wen S, Unuma K, Makino Y, et al. · Leg Med (Tokyo) · 2022Case Reports
- Evaluation of Efficacy and Safety of miraDry® Procedure in the Treatment of Primary Axillary Hyperhidrosis.
Wimmer F, Ramic A, Nolte JP, et al. · Aesthetic Plast Surg · 2025
- Patient satisfaction after miraDry® treatment for axillary hyperhidrosis. Results of an online patient survey after miraDry® treatment to reduce excessive axillary sweating.
Tanzella U, Ueberreiter K, Bell A, et al. · GMS Interdiscip Plast Reconstr Surg DGPW · 2024
- [Complications Following Treatment for Excessive Axillary Sweating With Microwaves: A Case Report].
Bayoux R, Barani C, Curings P, et al. · Ann Burns Fire Disasters · 2022Case Reports, English Abstract
- Potential use of microwave technology in dermatology.
Gupta AK, Venkataraman M, Joshi LT, et al. · J Dermatolog Treat · 2022Case Reports, Review
- Bilateral Brachial Plexus Injury After MiraDry Procedure for Axillary Hyperhidrosis.
Puffer RC, Bishop AT, Spinner RJ, et al. · World Neurosurg · 2019
- Conservative Management of Median Nerve Brachial Plexopathy after Microwave-based MiraDry Treatment for Axillary Hyperhidrosis.
Lee FG, Mansour AM, Wallace SJ, et al. · Plast Reconstr Surg Glob Open · 2021Case Reports
- Correction: Evaluation of Efficacy and Safety of miraDry® Procedure in the Treatment of Primary Axillary Hyperhidrosis.
Wimmer F, Ramic A, Nolte JP, et al. · Aesthetic Plast Surg · 2025Published Erratum
- A survey of long-term results with microwave energy device for treating axillary hyperhidrosis.
Lin MJ, Dubin DP, Genece J, et al. · J Cosmet Laser Ther · 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.